Xiaohui Peng

Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy.

G. Fenalti, L. LeBrun, Dan Zhu, 2019, Journal of medicinal chemistry.

Crystal structures of E. coli laccase CueO at different copper concentrations.

M. Zhang, W. Gong, Zhiyi Wei, 2007, Biochemical and biophysical research communications.

The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen.

L. LeBrun, Dan Zhu, B. Pagarigan, 2017, Journal of medicinal chemistry.

N114S mutation causes loss of ATP-induced aggregation of human phosphoribosylpyrophosphate synthetase 1.

Honglin Liu, Zhaofeng Luo, Shiqiang Wei, 2009, Biochemical and biophysical research communications.

Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity.

L. LeBrun, T. Tran, K. Leftheris, 2021, Journal of medicinal chemistry.